1-855-378-42281-855-378-4228
One of the outpatient rehab alternatives for people in Schodack Landing struggling with opioid abuse and addiction is called opioid maintenance therapy. Some clinics and doctors are certified to administer specific medications to opioid dependent people, many of which are opioids also and are addiction. With low doses the client does not experience high feelings and also doesn't experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first medication tried for this reason, but there are alternative choices currently to pick from.
Methadone is an opiate and is meant to be taken at an out-patient clinic licensed to dispense the med, that is taken on a daily basis in liquid or pill form. The cost of the med is around $150 per month. Buprenorphine is also an opioid-based drug, and is a pill often taken every other day. But different from Methadone that is only be dispensed in highly structured medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The cost monthly of buprenorphine is approximately $300 a month for the generic version of the med. There is also a version of buprenorphine that contains the ingredient naloxone, that is a drug that reverses the effects of opioids. Someone consuming this version of the drug, also known as Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It too is taken daily, and is priced about $450 per month. Naltrexone is an additional drug used in opioid maintenance therapy, but unlike the other drugs mentioned here it is an opiate blocker and is not an opioid. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, the drug prevents an individual from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 monthly.
For All Drug and Alcohol Rehab Facilities In Schodack Landing, Click Here.
